WO1999001475A3 - Humaner antikörper gegen ein fusions(poly)peptid bzw. -protein, das einen anteil von mindestens sechs histidinen aufweist - Google Patents
Humaner antikörper gegen ein fusions(poly)peptid bzw. -protein, das einen anteil von mindestens sechs histidinen aufweist Download PDFInfo
- Publication number
- WO1999001475A3 WO1999001475A3 PCT/DE1998/001882 DE9801882W WO9901475A3 WO 1999001475 A3 WO1999001475 A3 WO 1999001475A3 DE 9801882 W DE9801882 W DE 9801882W WO 9901475 A3 WO9901475 A3 WO 9901475A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- fusion
- poly
- histidines
- peptide
- human antibody
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/44—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
Abstract
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP50612799A JP2002500517A (ja) | 1997-07-04 | 1998-07-03 | 少なくとも6つのヒスチジンを有する部分をもつ融合(ポリ)ペプチドまたはタンパク質に対するヒト抗体 |
EP98943648A EP0996639A2 (de) | 1997-07-04 | 1998-07-03 | Humaner antikörper gegen ein fusions(poly)peptid bzw. -protein, das einen anteil von mindestens sechs histidinen aufweist |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE1997128697 DE19728697C1 (de) | 1997-07-04 | 1997-07-04 | Humaner Antikörper gegen ein Fusions(poly)peptid bzw. -protein, das einen Anteil von mindestens sechs Histidinen aufweist |
DE19728697.6 | 1997-07-04 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO1999001475A2 WO1999001475A2 (de) | 1999-01-14 |
WO1999001475A3 true WO1999001475A3 (de) | 1999-05-14 |
Family
ID=7834708
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/DE1998/001882 WO1999001475A2 (de) | 1997-07-04 | 1998-07-03 | Humaner antikörper gegen ein fusions(poly)peptid bzw. -protein, das einen anteil von mindestens sechs histidinen aufweist |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP0996639A2 (de) |
JP (1) | JP2002500517A (de) |
DE (1) | DE19728697C1 (de) |
WO (1) | WO1999001475A2 (de) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6699473B2 (en) * | 2000-10-13 | 2004-03-02 | Uab Research Foundation | Human anti-epidermal growth factor receptor single-chain antibodies |
CN1332202C (zh) * | 2005-11-30 | 2007-08-15 | 首都医科大学 | 一种利用蛋白质芯片研究蛋白质相互作用的方法 |
ES2618380T3 (es) | 2010-09-24 | 2017-06-21 | International Aids Vaccine Initiative | Novedosos anticuerpos con amplio poder neutralizante de VIH-1 |
AU2012347453B2 (en) | 2011-12-08 | 2017-11-23 | The United States Of America, As Represented By The Secretary Department Of Health And Human Services | Neutralizing antibodies to HIV-1 and their use |
CA2979219A1 (en) * | 2015-03-10 | 2016-09-15 | Sorrento Therapeutics, Inc. | Antibody therapeutics that bind psma |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0440147A2 (de) * | 1990-02-01 | 1991-08-07 | BEHRINGWERKE Aktiengesellschaft | Herstellung und Verwendung von Genbanken menschlicher Antikörper ("Human-Antikörper-Bibliotheken") |
WO1995023813A1 (en) * | 1994-03-04 | 1995-09-08 | Merck & Co., Inc. | In vitro antibody affinity maturation using alanine scanning mutagenesis |
DE19507166C1 (de) * | 1995-03-01 | 1996-04-18 | Deutsches Krebsforsch | Antikörper gegen ein Histidin-Fusionspolypeptid, das einen Histidin-Anteil aufweist |
-
1997
- 1997-07-04 DE DE1997128697 patent/DE19728697C1/de not_active Expired - Fee Related
-
1998
- 1998-07-03 EP EP98943648A patent/EP0996639A2/de not_active Withdrawn
- 1998-07-03 WO PCT/DE1998/001882 patent/WO1999001475A2/de not_active Application Discontinuation
- 1998-07-03 JP JP50612799A patent/JP2002500517A/ja active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0440147A2 (de) * | 1990-02-01 | 1991-08-07 | BEHRINGWERKE Aktiengesellschaft | Herstellung und Verwendung von Genbanken menschlicher Antikörper ("Human-Antikörper-Bibliotheken") |
WO1995023813A1 (en) * | 1994-03-04 | 1995-09-08 | Merck & Co., Inc. | In vitro antibody affinity maturation using alanine scanning mutagenesis |
DE19507166C1 (de) * | 1995-03-01 | 1996-04-18 | Deutsches Krebsforsch | Antikörper gegen ein Histidin-Fusionspolypeptid, das einen Histidin-Anteil aufweist |
Non-Patent Citations (2)
Title |
---|
DÜBEL ET AL.: "Generation of a human IgM expression library in E. coli", METHODS IN MOLECULAR AND CELLULAR BIOLOGY, vol. 3, 1992, pages 47 - 52, XP002096049 * |
WELSCHOF ET AL.: "The antigen-binding domain of a human IgG-anti-F(ab')2 autoantibody", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCE USA, vol. 94, March 1997 (1997-03-01), pages 1902 - 1907, XP002096050 * |
Also Published As
Publication number | Publication date |
---|---|
EP0996639A2 (de) | 2000-05-03 |
WO1999001475A2 (de) | 1999-01-14 |
JP2002500517A (ja) | 2002-01-08 |
DE19728697C1 (de) | 1999-03-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2203765A1 (en) | Cathepsin o2 protease | |
EP1176195A4 (de) | VERFAHREN ZUR KONTROLLE DER AKTIVITäT VON IMMUNOLOGISCH FUNKTIONELLEM MOLEKüL | |
AU9482098A (en) | Fusion protein systems | |
AU2455295A (en) | Protein or polypeptide, process for producing the same, and intermediate compound tehrefor | |
WO2001004265A3 (en) | C-terminal protein tagging | |
AU6059699A (en) | Synthetic peptides, conjugation reagents and methods | |
CA2220447A1 (en) | Novel fusion protein recovery and purification methods | |
WO1996027665A3 (en) | Neuron-restrictive silencer factor proteins | |
CY2341B1 (en) | Bicyclic amino acids. | |
WO1999025843A3 (en) | Human checkpoint kinase, hcds1, compositions and methods | |
EP0626450A3 (de) | Ubiquitinkonjugierendes Enzym (E2) enthaltende Fusionsproteine. | |
ZA969623B (en) | Fas Ligand fusion protein. | |
WO1999001475A3 (de) | Humaner antikörper gegen ein fusions(poly)peptid bzw. -protein, das einen anteil von mindestens sechs histidinen aufweist | |
ZA969402B (en) | Novel oligopeptides, the preparation and use thereof. | |
AU2486900A (en) | Rubredoxin fusion proteins, protein expression system and methods | |
CA2194032A1 (en) | Fused dna sequence, fused protein expressed from said fused dna sequence and method for expressing said fused protein | |
AU4483696A (en) | Novel peptides, their production and use | |
CA2199403A1 (en) | Novel PKA-Binding Proteins and Uses Thereof | |
EP0816498A3 (de) | Exzitatorische Aminosäure Rezeptor-Protein und verwante Nukleinsäure | |
AU5137698A (en) | Novel dna, novel protein, and novel antibody | |
ZA968185B (en) | Protein. | |
CA2199843A1 (en) | Novel PKA-Binding Proteins and Uses Thereof | |
AU4219397A (en) | Novel protein, its production and use | |
ZA9610510B (en) | Novel peptides, the preparation and use thereof. | |
AU7478098A (en) | Methods of treatment using nbs-1, antibodies and proteins thereto, and uses of the antibodies |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): JP US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): JP US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
ENP | Entry into the national phase |
Ref country code: JP Ref document number: 1999 506127 Kind code of ref document: A Format of ref document f/p: F |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1998943648 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1998943648 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 09462305 Country of ref document: US |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1998943648 Country of ref document: EP |